Logo image of EPOW

SUNRISE NEW ENERGY CO. LTD-A (EPOW) Stock Fundamental Analysis

NASDAQ:EPOW - Nasdaq - KYG3932F1063 - Common Stock - Currency: USD

0.9377  +0.03 (+3.85%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to EPOW. EPOW was compared to 82 industry peers in the Professional Services industry. EPOW may be in some trouble as it scores bad on both profitability and health. EPOW is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EPOW had negative earnings in the past year.
EPOW had a negative operating cash flow in the past year.
In the past 5 years EPOW reported 4 times negative net income.
In the past 5 years EPOW reported 4 times negative operating cash flow.
EPOW Yearly Net Income VS EBIT VS OCF VS FCFEPOW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

The Return On Assets of EPOW (-8.23%) is worse than 78.05% of its industry peers.
Industry RankSector Rank
ROA -8.23%
ROE N/A
ROIC N/A
ROA(3y)-16.43%
ROA(5y)-6.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EPOW Yearly ROA, ROE, ROICEPOW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EPOW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EPOW Yearly Profit, Operating, Gross MarginsEPOW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

EPOW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EPOW has been increased compared to 1 year ago.
Compared to 5 years ago, EPOW has more shares outstanding
Compared to 1 year ago, EPOW has a worse debt to assets ratio.
EPOW Yearly Shares OutstandingEPOW Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPOW Yearly Total Debt VS Total AssetsEPOW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

EPOW has an Altman-Z score of -0.42. This is a bad value and indicates that EPOW is not financially healthy and even has some risk of bankruptcy.
EPOW's Altman-Z score of -0.42 is on the low side compared to the rest of the industry. EPOW is outperformed by 82.93% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.42
ROIC/WACCN/A
WACC6.97%
EPOW Yearly LT Debt VS Equity VS FCFEPOW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

A Current Ratio of 0.73 indicates that EPOW may have some problems paying its short term obligations.
EPOW has a Current ratio of 0.73. This is amonst the worse of the industry: EPOW underperforms 87.80% of its industry peers.
A Quick Ratio of 0.52 indicates that EPOW may have some problems paying its short term obligations.
The Quick ratio of EPOW (0.52) is worse than 92.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.52
EPOW Yearly Current Assets VS Current LiabilitesEPOW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.66% over the past year.
EPOW shows a strong growth in Revenue. In the last year, the Revenue has grown by 44.28%.
EPOW shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.38% yearly.
EPS 1Y (TTM)52.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.58%
Revenue 1Y (TTM)44.28%
Revenue growth 3Y106.23%
Revenue growth 5Y29.38%
Sales Q2Q%75.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPOW Yearly Revenue VS EstimatesEPOW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EPOW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EPOW Price Earnings VS Forward Price EarningsEPOW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EPOW Per share dataEPOW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EPOW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNRISE NEW ENERGY CO. LTD-A

NASDAQ:EPOW (7/21/2025, 8:00:01 PM)

0.9377

+0.03 (+3.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)04-26 2024-04-26
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner ChangeN/A
Ins Owners8.56%
Ins Owner ChangeN/A
Market Cap25.31M
AnalystsN/A
Price TargetN/A
Short Float %0.09%
Short Ratio0.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS2.41
BVpS-0.38
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-16.43%
ROA(5y)-6.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.49%
Cap/Sales 3.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.52
Altman-Z -0.42
F-Score5
WACC6.97%
ROIC/WACCN/A
Cap/Depr(3y)773.17%
Cap/Depr(5y)734.51%
Cap/Sales(3y)43.68%
Cap/Sales(5y)52.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)44.28%
Revenue growth 3Y106.23%
Revenue growth 5Y29.38%
Sales Q2Q%75.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.51%
OCF growth 3YN/A
OCF growth 5YN/A